Daniel Wagner

Daniel Wagner is an experienced early stage life science investor and board member with a robust background in corporate acquisitions and IPOs. They served as a board observer for multiple companies, including Biohaven Pharmaceuticals, Medically Home, and Azitra Inc., contributing to significant events such as IPOs and acquisitions. Daniel held various investment roles at Connecticut Innovations from 2010 to 2012 and is currently the Senior Managing Director of Investments at the same organization. They earned an MBA in Finance and a Master of Health Science in Biomedical Sciences from Quinnipiac University, along with a BS in Biology from the University of Dayton.